Literature DB >> 4195203

Failure of corticosteroid therapy to correct the hypercalcaemia of malignant disease.

N C Thalassinos, G F Joplin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4195203     DOI: 10.1016/s0140-6736(70)91345-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Effect of salmon calcitonin and etidronate on hypercalcemia of malignancy.

Authors:  S Fatemi; F R Singer; R K Rude
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

Review 2.  Hypercalcaemia in malignancy.

Authors:  D A Heath
Journal:  BMJ       Date:  1989-06-03

Review 3.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

Review 4.  Drugs for disorders of bone: pharmacological and clinical considerations.

Authors:  G R Mundy; L G Raisz
Journal:  Drugs       Date:  1974       Impact factor: 9.546

5.  Skeletal metastases and mammary cancer.

Authors:  C S Galasko
Journal:  Ann R Coll Surg Engl       Date:  1972-01       Impact factor: 1.891

6.  Malignant hypercalcaemia.

Authors:  J C Stevenson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-17

7.  Disequilibrium hypercalcaemia.

Authors:  D J Hosking
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-29

8.  Management of severe hypercalcaemia.

Authors: 
Journal:  Br Med J       Date:  1980-01-26

9.  Treatment of hypercalcaemia associated with malignancy.

Authors:  R Wilkinson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-17

Review 10.  Medical management of hypercalcaemia.

Authors:  S H Ralston
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.